June 2023 – ESHRE has joined together with 31 other health stakeholders to develop specific recommendations for a potential opt-out mechanism in the future EHDS.

May 2023 – ESHRE has sent a letter to Members of the European Parliament to voice the position of MAR professionals on some of the amendments to the SoHO Regulation proposal that were tabled for a vote in the European Parliament.

January 2023 – ESHRE has welcomed the European Commission's proposal for a SoHO Regulation and actively voiced the views of MAR professionals on the elements of the proposal that should still be improved and clarified to ensure it brings maximum benefit to MAR patients, donors, and children born from MAR, as well as to professionals involved in MAR treatments.

October 2022 – ESHRE joined a group of 35 stakeholders in welcoming the European Commission’s proposal on the European Health Data Space and shares stakeholders’ recommendations on how to make the digital transformation a success across Europe.

June 2022 – ESHRE sets out several key topics related to infertility and MAR that should be considered for inclusion in research funding programmes, to advance the field of MAR as well as contribute to reducing the negative impacts of infertility.

May 2022 – ESHRE puts forward recommendations for responsible innovation, aiming to improve access to innovations for MAR patients, while at the same time ensuring the efficacy and safety of treatments.

February 2022 - ESHRE supports the position of ESHG on embryo selection based on polygenic risk scores

January 2022 - Europe needs registries to protect the intended parents, third-party donors and children born from Medically Assisted Reproduction

June 2021 - ESHRE is actively involved to ensure that the specificities of medically assisted reproduction are considered and the voice of MAR professionals is heard in the revision of the EUTCD.

2004 - EU Tissues and cells directive
2009 - Tissues directive viral screening